Quarterly ROE
2.98%
+0.40%+15.50%
September 30, 2024
Summary
- As of February 7, 2025, AFJK quarterly return on equity is 2.98%, with the most recent change of +0.40% (+15.50%) on September 30, 2024.
- Over the past year, AFJK quarterly ROE has increased by +2.98% (+100.00%).
- AFJK quarterly ROE is now at all-time high.
Performance
AFJK Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
AFJK ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +100.0% |
| 3 y3 years | - | +100.0% |
| 5 y5 years | - | +100.0% |
AFJK ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | ||
| 5 y | 5-year | at high | -100.0% | ||
| alltime | all time | at high | -100.0% |
Aimei Health Technology Co Ltd Ordinary Share ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 2.98%(+15.5%) |
| Jun 2024 | - | 2.58%(+59.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | 1.62%(>+9900.0%) |
| Dec 2023 | - | 0.00%(0.0%) |
| Sep 2023 | - | 0.00% |
FAQ
- What is Aimei Health Technology Co Ltd Ordinary Share quarterly return on equity?
- What is the all time high quarterly ROE for Aimei Health Technology Co Ltd Ordinary Share?
- What is Aimei Health Technology Co Ltd Ordinary Share quarterly ROE year-on-year change?
What is Aimei Health Technology Co Ltd Ordinary Share quarterly return on equity?
The current quarterly ROE of AFJK is 2.98%
What is the all time high quarterly ROE for Aimei Health Technology Co Ltd Ordinary Share?
Aimei Health Technology Co Ltd Ordinary Share all-time high quarterly return on equity is 2.98%
What is Aimei Health Technology Co Ltd Ordinary Share quarterly ROE year-on-year change?
Over the past year, AFJK quarterly return on equity has changed by +2.98% (+100.00%)